SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001387131-15-000450
Filing Date
2015-02-10
Accepted
2015-02-10 17:01:26
Documents
7
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10qa_123114.htm 10-Q/A 19303
  Complete submission text file 0001387131-15-000450.txt   1812643

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ohrp-20141231.xml EX-101.INS 184534
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20141231.xsd EX-101.SCH 21292
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20141231_cal.xml EX-101.CAL 35721
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20141231_def.xml EX-101.DEF 59196
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20141231_lab.xml EX-101.LAB 175182
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20141231_pre.xml EX-101.PRE 134377
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-35963 | Film No.: 15594669
SIC: 2834 Pharmaceutical Preparations